Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 116316
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116316
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116316
Figure 1 Family pedigree of the proband.
Black arrow: Our patient (the proband).
Figure 2 Relative abundance of fecal bacterial taxa in a pediatric patient with colon cancer and a matched healthy control.
The charts depict the composition of the fecal microbiota at the phylum, genus, and species levels, showing the relative abundance of each taxon in both individuals. Basic metadata for the patient and healthy control are included for comparison. A: Healthy control; B: Patient.
Figure 3 Clinical timeline of a pediatric patient with colon cancer from symptoms onset to current status.
Dates are shown in month/year format to clarify the chronological sequence of the patient’s clinical history. XELOX: Oral capecitabine and oxaliplatin; HIPEC: Hyperthermic intraperitoneal chemotherapy.
- Citation: Aldriwesh MG, Alhareeri A, Alswaji A, Hakami M, Almatrafi R, Alqarni A, Alhalafi M, Alselaim NA, Algarni M, Alawfi HG, Bosaeed M, Altammami M, Alghoribi MF. Colonic adenocarcinoma in a pediatric patient: A case report and review of literature. World J Gastrointest Oncol 2026; 18(5): 116316
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/116316.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.116316